Cargando…
Role of low plasma volume treatment on clinical efficacy of plasmapheresis in neuromyelitis optica
BACKGROUND: Neuromyelitis optica (NMO) is an autoimmune demyelinating disease preferentially targeting the optic nerves and spinal cord. Plasmapheresis (PP) is an effective adjunct therapy in severe NMO attacks. The recommended minimum plasma volume to be treated per session of PP is equivalent to t...
Autores principales: | Batra, Akshay, Periyavan, Sundar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5613414/ https://www.ncbi.nlm.nih.gov/pubmed/28970675 http://dx.doi.org/10.4103/ajts.AJTS_111_16 |
Ejemplares similares
-
Plasmapheresis for acute attacks in neuromyelitis optica spectrum disorders
por: Levy, Michael
Publicado: (2018) -
Plasmapheresis for acute attacks in neuromyelitis optica spectrum disorders
Publicado: (2018) -
Acute Respiratory Failure due to Neuromyelitis Optica Treated Successfully with Plasmapheresis
por: Zantah, Massa, et al.
Publicado: (2016) -
Clinical Efficacy of Plasmapheresis in Patients with Neuromyelitis Optica Spectrum Disorder and Effects on Circulating Anti-Aquaporin-4 Antibody Levels
por: Kim, Su-Hyun, et al.
Publicado: (2013) -
Therapeutic Efficacy of Plasma Exchange in Neuromyelitis Optica
por: Kumar, Rajesh, et al.
Publicado: (2018)